about
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal P...
Read More
6.96
-0.14
(-1.97%)
23,173
XNAS Volume
XNAS 29 Jul, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
BioVie Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..